Literature DB >> 8019502

Antagonism of the human thromboxane A2 receptor by an anti-asthmatic agent AA-2414.

T Kurokawa1, T Matsumoto, Y Ashida, R Sasada, S Iwasa.   

Abstract

The human thromboxane A2 receptor (TXA2-R)-coding gene was introduced into Chinese hamster ovary cells and a cell line (TCHO-25) stably expressing TXA2-R, at a level of 3 x 10(5)/cell, was obtained. An anti-asthmatic agent AA-2414 [(+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7- phenylheptanoic acid] competitively inhibited the specific binding of a TXA2 mimic ([3H]U-46619) to the TCHO-25 cells, with an IC50 of 6.0 x 10(-8) M, indicating that the drug is an antagonist of human TXA2-R. The TCHO-25 cells offer a tool for the screening and characterization of human TXA2-R antagonists.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019502     DOI: 10.1248/bpb.17.383

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection.

Authors:  Roohani Sharma; Puneet Kaur Randhawa; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-03       Impact factor: 3.000

2.  Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats.

Authors:  C Song; S Suzuki; H Kubo; M Chida; Y Hoshikawa; T Tabata; T Kondo
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

3.  Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.

Authors:  K Kasahara; M Fujimura; T Bando; K Shibata; H Shirasaki; T Matsuda
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.